<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>医麦客 | wechat-feeds</title><link>http://MzI0OTUwODU5Mg.favicon.privacyhide.com/favicon.ico</link><description>医麦客是一个聚焦转化医学、精准医疗和生物制药的专业媒体平台，持续关注体外诊断、抗体药物、细胞治疗、基因治疗等细分领域。为新生物医药医疗领域的企业发声，推动企业和行业的快速发展。</description><managingEditor> (hellodword)</managingEditor><pubDate>Thu, 25 Feb 2021 11:49:48 +0800</pubDate><image><url>http://MzI0OTUwODU5Mg.favicon.privacyhide.com/favicon.ico</url><title>医麦客 | wechat-feeds</title><link>http://MzI0OTUwODU5Mg.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>解读丨浅析CAR-T在中国的发展及监管状况</title><link>https://mp.weixin.qq.com/s/ThRq1G8gwsErHZdt6Dau1Q</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/bK2EFoTdFItUd6QqiavlwOVxjaTC0ibJfMfuqDwWUn8Dia3jmLVbZsiapCJpRKibGKDSDjdLIS7Q7via8Oe2hMQ5RQfg/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>细胞和基因治疗产品监管政策趋势与合规探讨]]></content:encoded><pubDate>Wed, 24 Feb 2021 21:58:44 +0800</pubDate></item><item><title>博腾生物GMP悬浮无血清慢病毒生产平台，助力基因与细胞治疗丨医麦猛爆料</title><link>https://mp.weixin.qq.com/s/ClLpZcJ1Zog4GzlV212vQw</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/bK2EFoTdFItUd6QqiavlwOVxjaTC0ibJfM2vduCl259PDOXTQCEWFOnrCBFb7OZtIJSaXIOxJSwZDcsbVlEy6t6Q/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>博腾生物已经成功建立了悬浮无血清慢病毒工艺开发和GMP生产平台，具有细胞培养上清病毒载体滴度高、无动物源性成分、工艺操作简单化、纯化工艺感染滴度回收率高、生产成本降低以及易于放大等优势。]]></content:encoded><pubDate>Wed, 24 Feb 2021 21:58:44 +0800</pubDate></item><item><title>静脉给药的溶瘤病毒联合CAR-T疗法有望治愈实体瘤丨医麦猛爆料</title><link>https://mp.weixin.qq.com/s/9mDINOvxMUph_gnSlTKlHA</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/bK2EFoTdFItUd6QqiavlwOVxjaTC0ibJfMC8NOP1rqNq6pBLduvYY3hvQl8tV26D71wOT2s53mTJVWbOWt0NMcFw/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>联合策略的又一力证]]></content:encoded><pubDate>Wed, 24 Feb 2021 21:58:44 +0800</pubDate></item><item><title>华龛生物第二款药辅资质获得CDE审批丨医麦猛爆料</title><link>https://mp.weixin.qq.com/s/-acWWhTYJhmrH33iu27TQg</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/bK2EFoTdFItUd6QqiavlwOVxjaTC0ibJfMQUovcLMSKr9CmVuvH455DnXFs7PCuh3dickgYgXYOpsRialaHHKEeS8w/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>第二款获得CDE药用辅料资质的产品]]></content:encoded><pubDate>Wed, 24 Feb 2021 21:58:44 +0800</pubDate></item><item><title>mRNA工程化CAR-T疗法启动2期临床试验，灵活的创新平台适用于各类细胞改造丨医麦猛爆料</title><link>https://mp.weixin.qq.com/s/Pom-eU96EOMMndmuXKHKvA</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/bK2EFoTdFItUd6QqiavlwOVxjaTC0ibJfM1N3Con4PibJpAI6icVTax9J8oicibNovKTA78mH7uhJaGEQia5qkr08wCaA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>短暂而非永久的表达CAR分子，提高安全性]]></content:encoded><pubDate>Wed, 24 Feb 2021 21:58:44 +0800</pubDate></item><item><title>专访卡替医疗CSO高斌教授：与癌症堡垒展开T细胞立体式作战</title><link>https://mp.weixin.qq.com/s/DQdEEss79vqF0seeR-bZlA</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/bK2EFoTdFItibdqytdbEzGfEdG0r87ISiciaWGibSicbAGCb6NOMicGZEUwuglGKHjX8CoNao5mDUZAdnkWDIFd1dRDg/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>TIL疗法或许是解决肿瘤异质性难题的好办法。]]></content:encoded><pubDate>Tue, 23 Feb 2021 19:23:39 +0800</pubDate></item><item><title>AAV大牛James Wilson领衔研究，一次基因编辑治疗成功降低动物模型三年的胆固醇丨医麦猛爆料</title><link>https://mp.weixin.qq.com/s/jcHSiDrJHlJThEAX6OdtMg</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/bK2EFoTdFItibdqytdbEzGfEdG0r87ISicHOAQQXcAbU4E48QbuWT9S134YkCN5UuBZzbb2ZB6EVsiap0gnlXiccbw/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>礼来看好的基因编辑技术！]]></content:encoded><pubDate>Tue, 23 Feb 2021 19:23:39 +0800</pubDate></item><item><title>抗癌基因疗法安全性良好，III期试验正在稳步推进丨医麦猛爆料</title><link>https://mp.weixin.qq.com/s/m0olZ1dmHAMeXHA3ZVTVFw</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/bK2EFoTdFItibdqytdbEzGfEdG0r87ISicqJOnQibxCzhsO6XZMJhuZggRvx9YJQaEI8IFryicMu9KtjphoQLG3iaRQ/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>有望治疗卵巢癌]]></content:encoded><pubDate>Tue, 23 Feb 2021 19:23:39 +0800</pubDate></item><item><title>CD19靶向药物开发百花齐放，恺佧生物推出新一代高活性定点荧光标记CD19蛋白丨医麦猛爆料</title><link>https://mp.weixin.qq.com/s/kBvhxEEV62CtMnRBRwnt0A</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/bK2EFoTdFIsib0wcEMAsyUDedFzoplibhZVTBJicQIGzlnuYick9EhtFl1k2AqwBibnbJqGWc2GQQ6MLzaicnVPbfhZg/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>闪闪发光的CD19靶点]]></content:encoded><pubDate>Tue, 23 Feb 2021 07:54:35 +0800</pubDate></item><item><title>实现基因疗法重复给药！免疫耐受平台助力的AAV步入临床试验丨医麦猛爆料</title><link>https://mp.weixin.qq.com/s/JIvC3xEeq8XNmlQLJkQ8AA</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/bK2EFoTdFIsib0wcEMAsyUDedFzoplibhZzfvfcAn3fGjNv5gkhA0G6Pzvazco1HlWaYrknaArZoubCLOY4Qpz5A/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>减少中和抗体形成，增强AAV疗效]]></content:encoded><pubDate>Tue, 23 Feb 2021 07:54:35 +0800</pubDate></item><item><title>药融资丨武田就下一代在体基因治疗达成最高12.5亿美元的合作</title><link>https://mp.weixin.qq.com/s/qrr8sJmpqPnQoqp2JG2gSg</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/bK2EFoTdFIsib0wcEMAsyUDedFzoplibhZh8Hb0iboHXRiagVsFdZEN64QwBUVicZsk2ja4CAXACE7ruxj0ZjiaaBjdQ/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>武田扩大基因疗法布局]]></content:encoded><pubDate>Tue, 23 Feb 2021 07:54:35 +0800</pubDate></item><item><title>中概医药股西比曼”私有化”成为焦点，国内细胞治疗市场潜能逐步放大丨医麦新观察</title><link>https://mp.weixin.qq.com/s/4ICfwj7J-omEaRRE5XbCNA</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/bK2EFoTdFIsib0wcEMAsyUDedFzoplibhZo6UPM6ib1X2MMErF6pAiaO8a3Zps6xx01vY7txHeUtn5dooGvI39hXicA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>交易总估值约为4.1亿美元]]></content:encoded><pubDate>Mon, 22 Feb 2021 09:49:48 +0800</pubDate></item><item><title>展会预告 | 上海倍笃生物约您BPIT 2021不见不散</title><link>https://mp.weixin.qq.com/s/ANUsBtVO1hBFyviQH36qwA</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/bK2EFoTdFIsib0wcEMAsyUDedFzoplibhZgqmCrCPkNnBB6JcRwTerGVyHa1Tic42sugBEGLHAxzjVgT1N1cRvlAQ/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>近百位国内生物创新药的权威领袖发言，数百家领先的生物制药企业密切关注，逾千位医药领域的同行报名参加，数十种创新药技术集体亮相]]></content:encoded><pubDate>Mon, 22 Feb 2021 09:49:48 +0800</pubDate></item><item><title>诺华Kymriah在各国的报销计划，国内即将迎来首款CAR-T细胞治疗丨医麦猛爆料</title><link>https://mp.weixin.qq.com/s/9hr3al9XArFM4PHgwAfsDw</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/bK2EFoTdFIsib0wcEMAsyUDedFzoplibhZePUqrJm5wOggybwibt3fAWFFiaY2Er540KIt5diaZOtCQ96uuiciaSjQOwA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>希望早日惠及更多患者]]></content:encoded><pubDate>Mon, 22 Feb 2021 09:49:48 +0800</pubDate></item><item><title>AAV递送脑源性神经营养因子，阿尔兹海默症基因疗法启动1期临床试验丨医麦猛爆料</title><link>https://mp.weixin.qq.com/s/p23LUnc7wisY5c8gCHR-uA</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/bK2EFoTdFIsjnxs2V6KBleianV9AJZquZzxgkQ8bXy36RuNU05s9ibwk7TmU4iaic0BoN1apeLWWfP9Dcsic9qZ8zkA/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>基因治疗能否为阿尔兹海默症带来获益？]]></content:encoded><pubDate>Mon, 22 Feb 2021 09:49:48 +0800</pubDate></item><item><title>金斯瑞蓬勃生物与SunRock Biopharma达成合作协议，共同开发新型单克隆抗体项目丨医麦猛爆料</title><link>https://mp.weixin.qq.com/s/nQBKUx4kTsd1TRIg7E7c5g</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/bK2EFoTdFIsjnxs2V6KBleianV9AJZquZJib0tVjrZg8obB6RvtDAH1LjoNsBAV52OCqtlMYvBqiaD8V4r6WdIcCw/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>靶向CCR9，为多种癌症带来新的可能。]]></content:encoded><pubDate>Sat, 20 Feb 2021 21:53:30 +0800</pubDate></item><item><title>治疗黑色素瘤！TCR公司Immunocore的双特异性蛋白获FDA突破性疗法资格丨医麦猛爆料</title><link>https://mp.weixin.qq.com/s/rCB_duG9-PFZhHQNjn6gxg</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/bK2EFoTdFIsjnxs2V6KBleianV9AJZquZ9InsBawVcaklHImT0nRloy9nGNWZCm2rOW4jpJ4ZZWmvLb2LzCRRBw/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>有望成为40年来治疗转移性葡萄膜黑色素瘤的第一种新疗法]]></content:encoded><pubDate>Sat, 20 Feb 2021 21:53:30 +0800</pubDate></item><item><title>新冠疫苗最新动态，强生、辉瑞/BioNTech、Novavax丨医麦新观察</title><link>https://mp.weixin.qq.com/s/iByPatU5sudL70LoYpvUSg</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/bK2EFoTdFIsjnxs2V6KBleianV9AJZquZjkxfsu4WuVhjjCvvpB9MDCw7ReYVjbu2TlYW4pWVV8DeJVzKrWvMdw/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>新冠疫苗全球布局加快]]></content:encoded><pubDate>Sat, 20 Feb 2021 21:53:30 +0800</pubDate></item><item><title>宾大团队发文：CAR-T迄今最长期的随访数据公布，治疗非霍奇金淋巴瘤取得又一好成绩丨医麦猛爆料</title><link>https://mp.weixin.qq.com/s/PE3KvnGCDz__KmmyFhbVdg</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/bK2EFoTdFIuOBrAPZXzkfkuV4UOdxOsI4Dfic1icn2BMiaEK0ic55AbYH9tTuFAQ9qDhh6UxdxjffXibD6QAXs01Jwg/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>CAR-T治疗5年后，患者都怎么样了？]]></content:encoded><pubDate>Sat, 20 Feb 2021 01:19:12 +0800</pubDate></item><item><title>重磅！国际首个自分泌PD-1 CAR-T细胞联合疗法临床实验数据公布！12年磨一剑，剑指实体瘤！丨医麦猛爆料</title><link>https://mp.weixin.qq.com/s/r2z9g7am8LzqzQnJ9mbuGA</link><description></description><content:encoded><![CDATA[<img src="http://mmbiz.qpic.cn/mmbiz_jpg/bK2EFoTdFIuOBrAPZXzkfkuV4UOdxOsIFNQjfusYIMuBcuwYtF897sr3wpcaaeKa6HFibJ6ezxR4zom31aibVxjQ/0?wx_fmt=jpeg" referrerpolicy="no-referrer"><br>患者无进展生存5个月，生存达17个月。]]></content:encoded><pubDate>Sat, 20 Feb 2021 01:19:12 +0800</pubDate></item></channel></rss>